Japan Mutual Aid Association of Public School Teachers Chugoku Central Hospital
Fukuyama, Hiroshima 7200001
0 studies enrolling now · 2 studies all time
What they study most
Chronic Cough, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic Syndrome
Studies at this site
- Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) — Completed
- Evaluation of S-600918 in Adults With Refractory Chronic Cough — Completed